Company Overview
About Sprout Pharmaceuticals
The company is located in the United States and specializes in the development and sale of Flibanserin, a medication approved for the treatment of premenopausal women with hypoactive sexual desire disorder. The medication is marketed under the brand name Addyi and is often referred to as the "female Viagra" or "pink Viagra." The company, Sprout Pharmaceuticals, obtained FDA approval for Flibanserin in August 2015.